Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1966 Mar;19(2):165–169. doi: 10.1136/jcp.19.2.165

Effects of desferrioxamine in patients with iron-loading with a simple method for estimating urinary iron

M S Losowsky 1
PMCID: PMC473221  PMID: 5909698

Abstract

Desferrioxamine produced marked increases in urinary iron excretion in three patients with very gross iron loading. The magnitude of the response to desferrioxamine was not closely related to the amount of iron seen in liver biopsy sections. In two patients with less severe iron loading, desferrioxamine produced no significant increase in urinary iron content. In the patients who responded, the effect of desferrioxamine did not diminish with repeated doses even over periods of up to a year.

The effectiveness of desferrioxamine was not increased by intravenous administration, water diuresis, mersalyl, or ammonium chloride.

A simple method for estimation of urinary iron is described, necessitating a minimum of glassware, and sufficiently accurate for clinical purposes.

Full text

PDF
165

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BYRD R. B., COOPER T. Hereditary iron-loading anemia with secondary hemochromatosis. Ann Intern Med. 1961 Jul;55:103–123. doi: 10.7326/0003-4819-55-1-103. [DOI] [PubMed] [Google Scholar]
  2. FIELDING J. DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON. J Clin Pathol. 1965 Jan;18:88–97. doi: 10.1136/jcp.18.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. FINCH S. C., BARNETT R. N. Diagnostic and therapeutic phlebotomy in hemochromatosis with anemia; report of a case. N Engl J Med. 1957 May 9;256(19):884–887. doi: 10.1056/NEJM195705092561904. [DOI] [PubMed] [Google Scholar]
  4. GELPI A. P., ENDE N. An hereditary anemia with hemochromatosis; studies of an unusual hemopathic syndrome resembling thalassemia. Am J Med. 1958 Aug;25(2):303–314. doi: 10.1016/0002-9343(58)90036-6. [DOI] [PubMed] [Google Scholar]
  5. GOLDISH R. J., AUFDERHEIDE A. C. Secondary hemochromatosis. II. Report of a case not attributable to blood transfusions. Blood. 1953 Sep;8(9):837–844. [PubMed] [Google Scholar]
  6. HENRY R. J., SOBEL C., CHIAMORI N. On the determination of serum iron and iron-binding capacity. Clin Chim Acta. 1958 Nov;3(6):523–530. doi: 10.1016/0009-8981(58)90004-4. [DOI] [PubMed] [Google Scholar]
  7. HWANG Y. F., BROWN E. B. EVALUATION OF DEFEROXAMINE IN IRON OVERLOAD. Arch Intern Med. 1964 Dec;114:741–753. doi: 10.1001/archinte.1964.03860120053003. [DOI] [PubMed] [Google Scholar]
  8. LOSOWSKY M. S., HALL R. HEREDITARY SIDEROBLASTIC ANAEMIA. Br J Haematol. 1965 Jan;11:70–85. doi: 10.1111/j.1365-2141.1965.tb00086.x. [DOI] [PubMed] [Google Scholar]
  9. PETERS T., GIOVANNIELLO T. J., APT L., ROSS J. F. A simple improved method for the determination of serum iron. II. J Lab Clin Med. 1956 Aug;48(2):280–288. [PubMed] [Google Scholar]
  10. SMITH R. S. CHELATING AGENTS IN THE DIAGNOSIS AND TREATMENT OF IRON OVERLOAD IN THALASSEMIA. Ann N Y Acad Sci. 1964 Oct 7;119:776–788. doi: 10.1111/j.1749-6632.1965.tb54079.x. [DOI] [PubMed] [Google Scholar]
  11. WALSH J. R., MASS R. E., SMITH F. W., LANGE V. DESFERRIOXAMINE EFFECT ON IRON EXCRETION IN HEMOCHROMATOSIS. Arch Intern Med. 1964 Mar;113:435–441. doi: 10.1001/archinte.1964.00280090121020. [DOI] [PubMed] [Google Scholar]
  12. WOEHLER F. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE. Acta Haematol. 1963 Aug;30:65–87. doi: 10.1159/000208110. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES